Patient preparation and standard stimulation regimens using gonadotropin-releasing hormone agonists

Clinical Obstetrics and Gynecology

Volumn 49, Issue 1, 2006, Pages 4-11

  Meldrum, David R ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Reproductive Partners Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSERELIN; CAFFEINE; DIETHYLSTILBESTROL; FOLLITROPIN; GONADORELIN AGONIST; LEUPRORELIN; LUTEINIZING HORMONE; NAFARELIN; ORAL CONTRACEPTIVE AGENT; RECOMBINANT FOLLITROPIN; SILDENAFIL; SPERM ANTIBODY;

CHLAMYDIA; CLINICAL TRIAL; DOSE RESPONSE; ENDOMETRIOSIS; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FLOW CYTOMETRY; GAMETE INTRAFALLOPIAN TRANSFER; GENETIC SCREENING; HEALTH PROGRAM; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL CULTURE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRACYTOPLASMIC SPERM INJECTION; LEUKOCYTE; MALE INFERTILITY; META ANALYSIS; PATIENT CARE; PREGNANCY OUTCOME; REVIEW; SCREENING TEST; SEMEN ANALYSIS; SEXUAL DYSFUNCTION; SMOKING HABIT; SPERMATOZOON PENETRATION; STAINING; SYSTEMATIC REVIEW; UTERUS MALFORMATION;

ANTIBODIES, BACTERIAL; CHLAMYDIA; FEMALE; FOLLICLE STIMULATING HORMONE; GENETIC SCREENING; GENETIC TESTING; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; MALE; OVULATION INDUCTION; RECEPTORS, GONADOTROPIN; SEMEN; SMOKING; SPERM-OVUM INTERACTIONS; SPERMATOZOA; UTERUS;

EID: 33748526849     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.grf.0000197504.52700.bf     Document Type: Review

References (19)

1. Grow DR, Oehninger S, Seltman HJ, et al. Sperm morphology as diagnosed by strict criteria: probing the impact of teratozoospermia on fertilization rate and pregnancy outcome in a large in vitro fertilization population. Fertil Steril. 1994;62:559-567.
2. Katayama KP, Stehlik E, Roesler M, et al. Treatment of human spermatozoa with an egg yolk medium can enhance the outcome of in vitro fertilization. Fertil Steril. 1989;52:1077-1079.
3. Greco E, Scarselli F, Iacobelli M, et al. Efficient treatment of infertility due to sperm DNA damage by ICSI with testicular spermatozoa. Hum Reprod. 2004;20:226-230.
4. Licciardo F, Grifo JA, Rosenwaks Z, et al. Relation between antibodies to Chlamydia trachomatis and spontaneous abortion following in vitro fertilization. J Assist Reprod Genet. 1992;9:207-210.
5. Abusheikha N, Lass A, Akagbosu F, et al. How useful is cervical dilation in patients with cervical stenosis who are participating in an in vitro fertilization-embryo transfer program? The Bourn Hall Experience. Fertil Steril. 1999;72:610.
6. Perez-Medina T, Bajo-Arenas J, Salazar F, et al. Endometrial polyps and their implication in the pregnancy rates of patients undergoing intrauterine insemination: a prospective, randomized study. Hum Reprod. 2005;20:1632-1635.
7. Mooney SB, Milki AA. Effect of hysteroscopy performed in the cycle preceding controlled ovarian hyperstimulation on the outcome of in vitro fertilization. Fertil Steril. 2003;79:637-638.
8. Surrey ES, Silverberg KM, Surrey MW, et al. Effect of prolonged gonadotropin- releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril. 2002;78:699-704.
9. Rickes D, Nickel I, Kropf S, et al. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril. 2002;78:757-762.
10. Karande VC, Lester RG, Muasher SJ, et al. Are implantation and pregnancy outcome impaired in diethylstilbestrol-exposed women after in vitro fertilization and embryo transfer. Fertil Steril. 1990;54:287-291.
11. Nichols JE, Crane MM, Higdon HL, et al. Extremes of body mass index reduce in vitro fertilization pregnancy rates. Fertil Steril. 2003;79:645-647.
12. Hughes EG, Fedorkow DM, Daya S, et al. The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials. Fertil Steril. 1992;58:888-896.
13. Pellicer A, Simon C, Miro F, et al. Ovarian response and outcome of in-vitro fertilization in patients treated with gonadotropin-releasing hormone analogues in different phases of the menstrual cycle. Hum Reprod. 1989;4:285-289.
14. Keltz MD, Jones EE, Duleba AJ, et al. Baseline cyst formation after luteal phase gonadotropin-releasing hormone agonist administration is linked to poor in vitro fertilization outcome. Fertil Steril. 1995;64:568-572.
15. Fanchin R, de Ziegler D, Taieb J, et al. Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil Steril. 1993;59:1090-1094.
16. Clark L, Stanger J, Brinsmead M. Prolonged follicle stimulation decreases pregnancy rates after in vitro fertilization. Fertil Steril. 1991;55:1192-1194.
17. Biljan MM, Mahutte NG, Dean N, et al. Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin-releasing hormone analogues and on subsequent implantation and pregnancy rates. Fertil Steril. 1998;70:1063-1069.
18. Westergaard LG, Laursen SB, Andersen CY. Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotropic women undergoing assisted reproduction. Hum Reprod. 2000;15:1003-1008.
19. Thompson KA, LaPolt PS, Rivier J, et al. Gonadotropin requirements of the developing follicle. Fertil Steril. 1995;63:273-276.